MedPath

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Not yet recruiting
Conditions
Gestational Diabetes
Hyperglycemia
Registration Number
NCT06184373
Lead Sponsor
Ohio State University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Women with a viable singleton intrauterine pregnancy<br><br> - Able to understand the study, and having understood, provide written informed<br> consent in English<br><br> - Recent pregnancy affected by gestational diabetes<br><br>Exclusion Criteria:<br><br> - Pregestational Diabetes (Type I or Type II)<br><br> - Continued use of diabetes medications (including metformin and insulin) immediately<br> after delivery<br><br> - Preterm delivery (< 37 weeks gestation)<br><br> - Twin or higher order gestation<br><br> - No access to a smartphone<br><br> - Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant<br> dyad clinic<br><br> - Participation in this trial in a prior pregnancy<br><br> - History of skin allergy to adhesive products or CGM

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acceptability of CGM;Comparative experience of OGTT and CGM
Secondary Outcome Measures
NameTimeMethod
Prevalence and characteristics of dysglycemia in GDM postpartum;Lifestyle changes survey;Medical care
© Copyright 2025. All Rights Reserved by MedPath